Healthtech

Indonesia’s Bumame raises Pre-Series A to expand

March 4, 2025
Image from Bumame

Here’s Bumame! This healthtech makes Indonesians aware of potential health issues before they develop into serious illnesses. Now, they just raised their Pre-Series A. 

  • Scoop: Bumame first launched in 2020, offering COVID-19 testing services. 

Investor check. Alpha JWC Ventures led the round, while 500 Global and Kopital Ventures also joined in. 

  • The amount raised was undisclosed. 

🔎 What the health?

Bumame offers proactive and preventive care, providing early detection services to help patients access accurate diagnostic results and health insights. 

Apart from that, they also make it easier for you to invest in your general wellness. 

  • Early cancer screening. They have screenings for common women’s and men’s cancers. 
  • Mom and baby. They offer end-to-end services for families in their family planning journey—from fertility tests to pregnancy and child check-ups.

Health is wealth. Oh, and they also offer complete health check-ups as well as vaccines and intravenous vitamin drips.

🥏 To healthcare and beyond

Bumame will use the $$$ to accelerate their digital transformation and expand their healthcare offerings. 

Know Southeast Asian tech in minutes.

The newsletter that keeps you up-to-date on the top stories on tech and business in Southeast Asia. It's fun, quick and free.
You're now subscribed to BackScoop. See you in your inbox!
Oops! Something went wrong while submitting the form.

Know Southeast Asian tech in minutes.

The newsletter that keeps you up-to-date on the top stories on tech and business in Southeast Asia. It's fun, quick and free.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.